Peer Review History
| Original SubmissionSeptember 12, 2025 |
|---|
|
Dear Dr. Lemieux, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Dec 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Wolfgang Blenau Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This study was supported by the following grants: two Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2021-02924 to H. Lemieux and RGPIN-2022-03629 to O. Rueppell), and a grant from the U.S. Army Research Office (W911NF-22-1-0195 to O. Rueppell).” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript. 4. Please note that your Data Availability Statement is currently missing the repository name and or a direct link to access each database. If your manuscript is accepted for publication, you will be asked to provide these details on a very short timeline. We therefore suggest that you provide this information now, though we will not hold up the peer review process if you are unable. 5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 6. We are unable to open your Supporting Information file “fig_s1 and fig_s2. Please kindly revise as necessary and re-upload. 7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: As you will see below, the two reviewers' opinions differ greatly. In order not to waste any more time obtaining a third opinion, I have tried to find a compromise with the recommendation “Major Revision.” I would ask you to take the methodological concerns of Reviewer #2 very seriously. Both reviewers have problems with the normalization step as performed in this study. Reviewer #2 also notes that critical tissue types should have been prepared more carefully. Furthermore, more specific information on the selection and status of the animals used is required. In addition, reviewer #1 makes a number of constructive suggestions for improving the introduction and requests additional details in the description of the methods. Reviewer #1 makes some suggestions for deepening the discussion. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: No ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: No ********** Reviewer #1: This study presents high-resolution respirometry results comparing young vs. old queen and worker honey bees, with the implicit aim of gaining insights into the possible role of mitochondrial function (OXPHOS pathways) in shaping the immense lifespan difference between the castes of social insects. After comparing body compartment size and of citrate synthase activity as a proxy of functional mitochondrial units, the experiments were performed on homogenates of head (mainly brain), thorax (mainly flight muscle) and abdominal (mainly fat body) tissues using an Oroboros system to measure the age-, caste-, and tissue-specific rates of mitochondrial respiration. The experiments were carefully performed and the protocols are described in sufficient detail to serve as guidance for follow-up studies building on this approach and the obtained results. The detailed methods description is also of importance readers not familiar with this methodology, so that they can capture and understand the results and the respective conclusions. This said, I only have a view comments and questions to this otherwise well-prepared manuscript. 1) A critical issue in presenting comparative HRR data is the normalization step. As far as I understand, the flux control ratios (FCRs) were calculated by normalization against the non-mitochondrial residual oxygen consumption (ROX). This, however, does not take into account the changes in functional mitochondrial units along the bees’ lifespan and tissue type, as shown in Figure 1, where this data is reported as citrate synthase activity, and where differences are clearly apparent for the head and abdomen. I certainly would expect that this factor can affect the interpretation of the results. 2) The authors compared their results to those of two prior studies that used a similar approach, and they explain why their results differ from those of these prior studies. While I agree with the argument for the first study (Menai et al.), the second study (Cervoni et al.) was criticized for having been performed in intact tissue and not in a homogenate. This, however, relates to the question whether a study examining the cellular physiology should be performed on intact cells in a tissue context, or whether a homogenate with mitochondria separated from the cellular context would be better representation. Both have drawbacks, on the one hand less control over the accessibility of the added compounds to the (unpermeabilized) mitochondria, while on the other, the cytoplasmic context is lost. 3) One issue that is of relevance in bioenergetics and metabolism is the type of diet consumed by the experimental animals. In the case of honey bees, there is a major difference in the diet consumed by young workers (high protein/lipid) compared to old workers (essentially only carbohydrate) and to queens, where both young and old queens receive royal jelly (high protein/lipid) from the workers. Adding a sentence or two on this would enrich the discussion. 4) The legends for Figures 2-4 are very similar, showing the datasets separately for head, thorax, and abdominal tissues. Hence, for Figures 3 and 4 the legend text could be condensed. 5) Unfortunately I could not access the data deposited in DRYAD, but I trust that they will be made available upon publication. Reviewer #2: The goal of PLoS ONE is to publish high quality studies irrespective of novelty in the field. I found that this study addresses an important and interesting (and novel) topic, but the quality of the study and presentation have significant limitations. I have substantial concerns about the methodology; as it was carried out, the approach limits the interpretability of the data. Some of these limitations are clear, and there are other places where the Methods are not complete enough to interpret the results. I focused my comments on the Introduction and Methods, because in my opinion, these substantial concerns would need to be addressed before it is worth addressing the Results and Discussion. I provide details about my concerns in the attached document. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 1 |
|
Tissue-Specific Mitochondrial Pathway Remodeling Linked to Longevity in Honeybee Queens PONE-D-25-49904R1 Dear Dr. Lemieux, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Wolfgang Blenau Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: (No Response) ********** Reviewer #1: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-25-49904R1 PLOS One Dear Dr. Lemieux, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Wolfgang Blenau Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .